About: Matthew B. Stern

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Matthew B. Stern Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher

Attributes	Values
rdf:type	Item
description	ikertzailea (eu) researcher (en) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) वैज्ञानिक (hi) изилдөөчү (ky)
rdfs:label	Matthew B. Stern (en) Matthew B. Stern (es) Matthew B. Stern (nl) Matthew B. Stern (ast)
skos:prefLabel	Matthew B. Stern (en) Matthew B. Stern (es) Matthew B. Stern (nl) Matthew B. Stern (ast)
name	Matthew B. Stern (en) Matthew B. Stern (es) Matthew B. Stern (nl) Matthew B. Stern (ast)
given name	wds:Q67208124-0D168B65-9985-45FA-9767-BDE905B99F2D
given name	Matthew
instance of	wds:Q67208124-FC1D22F6-8B37-4C3C-9389-30D8F13E492C
instance of	Homo sapiens
Semantic Scholar author ID	wds:Q67208124-F8288ACA-91D3-4E81-92E7-CB4DFBAC9945
Semantic Scholar author ID	4288397
skos:altLabel	M B Stern (en) M B Stern (es) M B Stern (nl) M B Stern (ast) Matthew B Stern (en)
occupation	wds:Q67208124-5E6D2785-4862-4359-9924-71FA15BEE527
NUKAT ID	wds:Q67208124-B56107A3-D71D-4883-A08A-6C418E8BA0EF
sex or gender	wds:Q67208124-57c6aead-d7a6-446f-984c-8901ef4878b0
ISNI	wds:Q67208124-D5FC1AC5-64CA-4CA6-B4F3-68CE55532E76
VIAF ID	wds:Q67208124-afbf5a84-4481-14eb-3b68-f035ad1a94aa
Library of Congress authority ID	wds:Q67208124-3b356ef2-4277-455b-2f94-a9b9481d0cb4
IdRef ID	wds:Q67208124-59ffcd27-3a66-466c-b0e4-8b91db468051
family name	wds:Q67208124-485CA17E-C127-425C-B2F1-8ECC3A536F39
VIAF ID	http://viaf.org/viaf/194873829
Library of Congress authority ID	http://id.loc.gov/authorities/names/n88038563
IdRef ID	http://www.idref.fr/086052292/id
occupation	researcher
NUKAT ID	n2009078764
sex or gender	male
ISNI	0000000032119293
VIAF ID	194873829
Library of Congress authority ID	n88038563
IdRef ID	086052292
family name	Stern
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q67208124
is author of	Information processing speed and sentence comprehension in Parkinson's disease. Use of natural killer cells in hematopoetic stem cell transplantation Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease Falling risk factors in Parkinson's disease Apolipoprotein E controls the risk and age at onset of Parkinson disease. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score Preclinical diagnosis of Parkinson's disease: are we there yet? Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy The preclinical detection of Parkinson's disease: ready for prime time? Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease Antidepressant studies in Parkinson's disease: a review and meta-analysis Recognition and treatment of depression in Parkinson's disease Age at onset in two common neurodegenerative diseases is genetically controlled Complete genomic screen in Parkinson disease: evidence for multiple genes. Grammatical and resource components of sentence processing in Parkinson's disease: an fMRI study. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease Supranuclear vertical gaze abnormalities in sporadic Creutzfeldt-Jakob disease The scientific and clinical basis for the treatment of Parkinson disease (2009). Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes Premotor Parkinson's disease: clinical features, detection, and prospects for treatment. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Psychiatric complications in Parkinson disease Parkin mutations and susceptibility alleles in late-onset Parkinson's disease Assessing resource demands during sentence processing in Parkinson's disease. Cognitive and physiological substrates of impaired sentence processing in Parkinson's disease. Cognitive resource limitations during sentence comprehension in Parkinson's disease Milestones in Parkinson's disease therapeutics Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria MDS research criteria for prodromal Parkinson's disease Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial Milestones in Parkinson's disease--clinical and pathologic features Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease Genetic influences on cognitive decline in Parkinson's disease Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers. Association of dopamine agonist use with impulse control disorders in Parkinson disease Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. Subthalamic nucleus deep brain stimulation for severe idiopathic dystonia: impact on severity, neuropsychological status, and quality of life. Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 126 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software